A PHASE 2 STUDY OF TRASTUZUMAB EMTANSINE IN JAPANESE PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER

被引：0
作者：
Takahashi, S.
Kashiwaba, M. [1 ]
Takao, S. [2 ]
Ito, Y.
Doihara, H. [3 ]
Rai, Y.
Matsubara, M.
Kanatani, K.
Masuda, N. [4 ]
机构：
[1] Iwate Med Univ, Morioka, Iwate, Japan
[2] Hyogo Canc Ctr, Kobe, Hyogo, Japan
[3] Okayama Univ Hosp, Okayama, Japan
[4] NHO Osaka Natl Hosp, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer
    Meng Zhao
    Xueliang Pan
    Rachel Layman
    Maryam B. Lustberg
    Ewa Mrozek
    Erin R. Macrae
    Robert Wesolowski
    Sarah Carothers
    Shannon Puhalla
    Charles L. Shapiro
    Bhuvaneswari Ramaswamy
    Investigational New Drugs, 2014, 32 : 1285 - 1294
  • [22] Ado-Trastuzumab Emtansine (Kadcyla) for HER2-Positive Metastatic Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1425): : 75 - 76
  • [23] Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence?
    Ricci, Francesco
    Le Tourneau, Christophe
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [24] Changes in the expression of HER2 and other genes in HER2-positive metastatic breast cancer induced by treatment with ado-trastuzumab emtansine and/or pertuzumab/trastuzumab
    Kida, K.
    Lee, J.
    Liu, H.
    Lim, B.
    Murthy, R. K.
    Sahin, A. A.
    Tripathy, D.
    Ueno, N. T.
    CANCER RESEARCH, 2019, 79 (04)
  • [25] Phase I trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
    Mundi, P. S.
    Lee, S.
    Chi, D.
    Bhardwaj, A.
    Makower, D.
    Cigler, T.
    Crew, K. D.
    Hershman, D. L.
    Califano, A.
    Silva, J.
    Kalinsky, K. M.
    CANCER RESEARCH, 2017, 77
  • [26] A Multicenter Phase 2 Study (JO22997) Evaluating the Efficacy and Safety of Trastuzumab Emtansine in Japanese Patients With Heavily Pretreated HER2-Positive Metastatic Breast Cancer
    Masuda, N.
    Ito, Y.
    Takao, S.
    Doihara, H.
    Rai, Y.
    Horiguchi, J.
    Kohno, N.
    Fujiwara, Y.
    Tokuda, Y.
    Watanabe, J.
    Iwata, H.
    Ishiguro, H.
    Miyoshi, Y.
    Matsubara, M.
    Kashiwaba, M.
    CANCER RESEARCH, 2012, 72
  • [27] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19) : 1783 - 1791
  • [28] Pertuzumab and trastuzumab-emtansine in HER2 positive metastatic colorectal cancer: the HERACLES B TRIAL
    Sartore-Bianchi, A.
    Marsoni, S.
    Trusolino, L.
    Martino, C.
    Lonardi, S.
    Leone, F.
    Cottino, F.
    Vurchio, V.
    Valtorta, E.
    Lauricella, C.
    Zagonel, V.
    Racca, P.
    Ciardiello, F.
    Ardizzoni, A.
    Tonini, G.
    Aglietta, M.
    Siena, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Radiolabeled trastuzumab biodistribution and serum HER2 levels in HER2-positive metastatic breast cancer patients
    Perik, Patrick J.
    Lub-de Hogge, Marjolijn N.
    Gietema, Jourik A.
    Jager, Piet L.
    Kosterink, Jos G.
    de Korte, Sander A.
    van Veldhuisen, Drik J.
    van der Graaf, Winette T.
    Sieijfer, Drik T.
    de Vries, Elisabeth G.
    ANNALS OF ONCOLOGY, 2004, 15 : 14 - 14
  • [30] HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
    Lee, Hee Jin
    Seo, An Na
    Kim, Eun Joo
    Jang, Min Hye
    Suh, Koung Jin
    Ryu, Han Suk
    Kim, Yu Jung
    Kim, Jee Hyun
    Im, Seock-Ah
    Gong, Gyungyub
    Jung, Kyung Hae
    Park, In Ae
    Park, So Yeon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (06) : 755 - 766
12345